Genetic Analysis of Multiple Primary Malignant Tumors in Women with Breast and Ovarian Cancer
Open Access
- 4 April 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6705
Abstract
Familial cancer syndromes, which are commonly caused by germline mutations in oncogenes and tumor suppressor genes, are generally considered to be the cause of primary multiple malignant neoplasias (PMMNs). Using targeted genomic sequencing, we screened for eight germline mutations: BRCA1 185delAG, BRCA1 T300G, BRCA1 2080delA, BRCA1 4153delA, BRCA1 5382insC, BRCA2 6174delT, CHEK2 1100delC, and BLM C1642T, which provoke the majority of cases of hereditary breast and ovary cancer syndrome (HBOC), in genomic (blood) DNA from 60 women with PMMNs, including breast (BC) and/or ovarian cancer(s) (OC). Pathogenic allelic forms were discovered in nine samples: in seven instances, it was BRCA1 5382insC, and in the following two, BRCA1 4153delA and BRCA1 T300G. The age of onset in these patients (46.8 years) was younger than in the general Russian population (61.0) for BC but was not for OC: 58.3 and 59.4, correspondingly. There were invasive breast carcinomas of no special type and invasive serous ovarian carcinomas in all cases. Two or more tumors of HBOC-spectrum were only in five out of nine families of mutation carriers. Nevertheless, every mutation carrier has relatives who have developed malignant tumors.Keywords
Funding Information
- Budgetary financing project (FGMU-2022-0004, N1021050601085-9-1.6.4, 3.1.6)
This publication has 38 references indexed in Scilit:
- Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type alleleMedical Oncology, 2014
- The population impact of familial cancer, a major cause of cancerInternational Journal of Cancer, 2013
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Cancer Epidemiology, Biomarkers & Prevention, 2012
- High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in RussiaInternational Journal of Cancer, 2011
- Reproductive History and Risk of Colorectal Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 2011
- Sarcomes utérins après exposition au tamoxifène dans les suites d’un cancer du sein : mise au point sur l’étiopathogénieJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2009
- Family history of hormonal cancers and colorectal cancer risk: A case‐control study conducted in OntarioInternational Journal of Cancer, 2009
- Estrogen receptor status in CHEK2‐positive breast cancers: implications for chemopreventionClinical Genetics, 2008
- Oestrogen‐mediated phosphorylation and stabilization of BRCA2 protein in breastThe Journal of Pathology, 2008
- Counseling for male BRCA mutation carriers – a reviewThe Breast, 2008